BlackRock Fund Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5.62M | Sell |
545,973
-213,029
| -28% | -$2.19M | ﹤0.01% | 2878 |
|
|
2016
Q3 | $7.67M | Buy |
759,002
+46,938
| +7% | +$475K | ﹤0.01% | 2618 |
|
|
2016
Q2 | $8M | Buy |
712,064
+25,029
| +4% | +$281K | ﹤0.01% | 2533 |
|
|
2016
Q1 | $9.39M | Buy |
687,035
+15,701
| +2% | +$214K | ﹤0.01% | 2388 |
|
|
2015
Q4 | $12.7M | Sell |
671,334
-45,084
| -6% | -$855K | ﹤0.01% | 2309 |
|
|
2015
Q3 | $13.4M | Buy |
716,418
+27,437
| +4% | +$515K | ﹤0.01% | 2240 |
|
|
2015
Q2 | $10.3M | Buy |
688,981
+439,331
| +176% | +$6.54M | ﹤0.01% | 2482 |
|
|
2015
Q1 | $3.78M | Buy |
249,650
+16,746
| +7% | +$254K | ﹤0.01% | 2965 |
|
|
2014
Q4 | $3.1M | Buy |
232,904
+214,118
| +1,140% | +$2.85M | ﹤0.01% | 3068 |
|
|
2014
Q3 | $237K | Sell |
18,786
-1,360
| -7% | -$17.2K | ﹤0.01% | 3416 |
|
|
2014
Q2 | $203K | Sell |
20,146
-162,494
| -89% | -$1.64M | ﹤0.01% | 3485 |
|
|
2014
Q1 | $2.46M | Buy |
+182,640
| New | +$2.46M | ﹤0.01% | 3116 |
|